Today's Updates

FDA Approves Venglustat as First Therapy for Neurological Manifestations of Type 3 Gaucher Disease Isabella Ciccone, MPH
Published Date: 21 Nov 2026

The FDA approved oral venglustat for neurological manifestations of type 3 Gaucher disease after the phase 3 LEAP2MONO trial showed superiority over imiglucerase on a combined ataxia and cognition measure.

Read More
ALS Prevention, Gene Therapy, and Newborn Screening at MDA 2027 Brian Lin, PhD, Isabella Ciccone, MPH
Published Date: 21 Nov 2026

Brian Lin, PhD, senior director of research at the Muscular Dystrophy Association (MDA), discussed the sessions he is most excited about at the 2027 MDA Clinical and Scientific Conference.

Read More
Neflamapimod Phase 2a Data in Primary Progressive Aphasia Show Exposure-Linked NfL Decline Isabella Ciccone, MPH
Published Date: 21 Nov 2026

In a phase 2a trial presented at CTAD 2026, neflamapimod kept plasma NfL stable in nonfluent variant primary progressive aphasia over 24 weeks.

Read More
Pooled Review Finds No Benefit, More Bleeding With Distal Clot Removal Marco Meglio
Published Date: 21 Nov 2026

Three randomized trials pooled in a new systematic review found that thrombectomy did not improve 90-day functional outcomes after medium or distal vessel occlusion stroke, while increasing bleeding risk.

Read More

Latest News


Latest News

News All Time


Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Three out of ten breast cancers detected between screenings, study finds

2.

Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments

3.

Where Did This Very Painful Gluteal Mass Come From?

4.

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.

5.

Rucaparib Delays Next Lines of Therapy in Ovarian Cancer



© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot